Загрузка...
Phytomedicine as a source of SGLT2 inhibitors, GLP-1 secretagogues and DPP-IV inhibitors for mitigation of Diabetic Nephropathy
Background: Diabetic nephropathy (DN) has been the major contributor to chronic kidney disease (CKD), end stage renal disease (ESRD), and cardiovascular risks. Incretin pathway modulators (GLP-1 analogs, GLP-1R agonist, GLP-1 secretagogues and DPP-IV inhibitors) and SGLT2 inhibitors are presently th...
Сохранить в:
| Главные авторы: | , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Elsevier
2022-05-01
|
| Серии: | Phytomedicine Plus |
| Предметы: | |
| Online-ссылка: | http://www.sciencedirect.com/science/article/pii/S2667031322000112 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|